News headlines about Albemarle Corporation (NYSE:ALB) have trended somewhat positive recently, according to Accern Sentiment Analysis. The research group scores the sentiment of press coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Albemarle Corporation earned a daily sentiment score of 0.08 on Accern’s scale. Accern also gave headlines about the specialty chemicals company an impact score of 45.1992160421375 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

These are some of the headlines that may have impacted Accern’s scoring:

Several brokerages have recently weighed in on ALB. Jefferies Group LLC set a $144.00 target price on shares of Albemarle Corporation and gave the company a “buy” rating in a research note on Monday, August 21st. SunTrust Banks, Inc. downgraded shares of Albemarle Corporation from a “buy” rating to a “hold” rating and set a $121.00 target price for the company. in a research note on Wednesday, August 9th. Vertical Research restated a “hold” rating and issued a $109.00 target price (up from $108.00) on shares of Albemarle Corporation in a research note on Thursday, August 10th. BidaskClub downgraded shares of Albemarle Corporation from a “buy” rating to a “hold” rating in a research note on Wednesday, August 2nd. Finally, CIBC began coverage on shares of Albemarle Corporation in a research note on Thursday, August 17th. They set an “outperform” rating and a $133.00 price objective on the stock. Seven research analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has given a strong buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average price target of $110.94.

Shares of Albemarle Corporation (NYSE ALB) opened at 116.26 on Friday. The firm’s 50 day moving average is $115.90 and its 200-day moving average is $108.75. Albemarle Corporation has a one year low of $75.11 and a one year high of $123.48. The firm has a market capitalization of $12.84 billion, a PE ratio of 14.87 and a beta of 1.59.

Albemarle Corporation (NYSE:ALB) last posted its quarterly earnings results on Monday, August 7th. The specialty chemicals company reported $1.13 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.11 by $0.02. Albemarle Corporation had a net margin of 31.49% and a return on equity of 11.59%. The firm had revenue of $737.25 million for the quarter, compared to the consensus estimate of $735.50 million. During the same quarter in the previous year, the company earned $0.93 earnings per share. The business’s revenue was up 10.1% compared to the same quarter last year. On average, equities research analysts predict that Albemarle Corporation will post $4.36 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Monday, October 2nd. Shareholders of record on Friday, September 15th will be paid a dividend of $0.32 per share. The ex-dividend date is Thursday, September 14th. This represents a $1.28 dividend on an annualized basis and a yield of 1.10%. Albemarle Corporation’s dividend payout ratio is currently 16.41%.

In other Albemarle Corporation news, CFO Scott Tozier sold 25,000 shares of Albemarle Corporation stock in a transaction on Friday, July 7th. The shares were sold at an average price of $110.13, for a total transaction of $2,753,250.00. Following the sale, the chief financial officer now owns 57,506 shares in the company, valued at $6,333,135.78. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Karen G. Narwold sold 20,000 shares of Albemarle Corporation stock in a transaction on Monday, June 19th. The stock was sold at an average price of $108.16, for a total transaction of $2,163,200.00. Following the sale, the executive vice president now owns 45,120 shares in the company, valued at approximately $4,880,179.20. The disclosure for this sale can be found here. Insiders have sold 121,897 shares of company stock worth $13,458,086 in the last quarter. Corporate insiders own 0.74% of the company’s stock.

WARNING: “Albemarle Corporation (ALB) Given Daily Coverage Optimism Rating of 0.08” was reported by Watch List News and is the property of of Watch List News. If you are accessing this piece on another website, it was illegally copied and republished in violation of U.S. and international trademark & copyright law. The legal version of this piece can be read at https://www.watchlistnews.com/albemarle-corporation-alb-given-daily-coverage-optimism-rating-of-0-08/1535073.html.

About Albemarle Corporation

Albemarle Corporation is a global developer, manufacturer and marketer of highly-engineered specialty chemicals. The Company operates through three segments: Lithium and Advanced Materials, Bromine Specialties and Refining Solutions. Lithium and Advanced Materials segment consist of two product categories: Lithium and Performance Catalyst Solutions.

Insider Buying and Selling by Quarter for Albemarle Corporation (NYSE:ALB)

Receive News & Ratings for Albemarle Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.